In more faked peer review news…10 papers pulled by Hindawi

Screen Shot 2015-12-18 at 9.57.36 AMGuess what? We’ve got more cases of fraudulent peer review to report — our second post of the day on the subject, in fact. In the latest news, Hindawi Publishing Corporation has retracted 10 papers for “fraudulent review reports,” after an investigation of more than 30 papers that had been flagged this summer.

The investigation found that author Jason Jung, a computer engineer at Yeungnam University in Korea, “was involved in submitting the fraudulent review reports” for four of the retracted papers, according to the publisher’s CEO. In the case of the other six, the authors didn’t appear to be involved.

Hindawi Publishing Corporation, which publishes over 400 journals, doesn’t ask authors for potential review suggestions — making a common route to fake peer review more difficult.  In July, when Hindawi announced it was investigating the papers, it posted a statement saying that they suspected the editors had created fake reviewer accounts.

The retraction note on Jung’s papers — identical except for the title at the beginning — explains that each paper has

Continue reading In more faked peer review news…10 papers pulled by Hindawi

“Compromised” peer review hits three papers from Nature Publishing Group

company-info-big

Nature Publishing Group is retracting three papers today, after an investigation found evidence the peer-review process had been compromised.

The publisher issued a statement saying they had notified corresponding authors and institutions associated with the three papers, which were all published last year in the journals Cancer Gene Therapy and Spinal Cord. 

Here’s the note that’s going on each of the papers, (they’re the same, except for the publication date):

Continue reading “Compromised” peer review hits three papers from Nature Publishing Group

“The peer review process was compromised”: Inflammation drug paper pulled

12

A paper that screened for antibodies that target TNFα, a major source of inflammation, has been retraction after an investigation revealed the peer-review process may have been compromised.

We’ve seen the peer review process “compromised” in a handful of ways — from a mathematician who oversaw the process on several of his own papers, to some 250 papers subject to outright fake peer review. The note for this paper, published in Amino Acids, doesn’t go into details, so we can only wonder what happened in this particular case.

Here’s the note for “Structure‑based development and optimization of therapy antibody drugs against TNFα:”

Continue reading “The peer review process was compromised”: Inflammation drug paper pulled

Biology journal bans plagiarizers, reviewers with non-institutional email addresses

87959_relDNA and Cell Biology has declared it will ban any authors who submit plagiarized manuscripts for three years, and will no longer accept suggestions of reviewers with non-institutional email addresses.

The move comes after a wave of hundreds of retractions stemming from fake peer reviews, often occurring when authors supply fake emails for suggested reviewers.

In an editorial published online October 23, editor Carol Shoshkes Reiss notes that the decision to ban authors who plagiarize material stems from a rash of recent submissions containing overlapping text: Continue reading Biology journal bans plagiarizers, reviewers with non-institutional email addresses

P53 researcher submitted paper “without permission from his co-authors”

Screen Shot 2015-10-20 at 1.23.37 PM

One issue that we see pretty regularly is a paper submitted by one author without the permission of the others.

That’s what’s happened with “p53-induced Rap2B positively regulates migration in cells exposed to glucose deprivation,” published in July by Molecular Carcinogenesis. The paper looks at a protein called p53, well-known to regulate cell growth and, when mutated, cause cancer.

Here’s the pretty straightforward retraction note:

Continue reading P53 researcher submitted paper “without permission from his co-authors”

Elsevier retracting nine papers for fake peer review

elsevierThe fake peer review retraction count continues to mount.

Elsevier is retracting nine papers from five journals because fake email addresses for reviewers were provided during submission of the original manuscripts. According to a statement from the publisher: Continue reading Elsevier retracting nine papers for fake peer review

“Rigging of the peer-review process” kills parasite paper

s13369083k

A paper on nematode parasites appears to have been infected with a nasty strain of a publishing problem known as fake peer review. By our count, the phenomenon has felled approximately 250 papers in total.

The affected review, “The important role of matrix metalloproteinases in nematode parasites,” explores a type of enzyme secreted by the parasite. Published in Helminthologia, it’s been cited once, according to Thomson Scientific’s Web of Knowledge.

Unfortunately, the retraction note doesn’t give us too many details about how the peer review process was manipulated:

Continue reading “Rigging of the peer-review process” kills parasite paper

17 retractions from SAGE journals bring total fake peer review count to 250

sage-journals-logoOn Monday, we reported on 64 new retractions from Springer journals resulting from fake peer reviews. Yesterday, SAGE — which retracted 60 papers for the same reason just over a year ago — added 17 additional retractions to their list.

The articles were published in five different journals, and one retraction involved authorship fraud in addition to peer review fraud, according to a SAGE spokesperson: Continue reading 17 retractions from SAGE journals bring total fake peer review count to 250

64 more papers retracted for fake reviews, this time from Springer journals

springerThis is officially becoming a trend: Springer is pulling another 64 articles from 10 journals after finding evidence of faked peer reviews, bringing the total number of retractions from the phenomenon north of 230.

Given that there have been about 1,500 papers retracted overall since 2012, when we first reported on the phenomenon, faked reviews have been responsible for about 15% of all retractions in the past three years.

This isn’t the first time Springer has faced the issue. As owner of the BioMed Central journals, it issued 43 retractions for faked reviews earlier this year.

In a statement, the publisher explains how the latest round of retractions came to light: Continue reading 64 more papers retracted for fake reviews, this time from Springer journals

BMC editors update retraction after investigation clears authors of faking peer reviews

bmc-logo

Editors at BioMed Central have taken the unusual step of updating a retraction notice after an investigation found the authors were not responsible for a peer review process gone awry. The paper is one of  dozens of other papers retracted in March for fake peer reviews.

That month, the paper “Clinical application of contrast enhanced ultrasound to diagnose benign prostatic hyperplasia” in Diagnostic Pathology was among the 43 papers retracted due to fake peer reviews. (Retractions for the phenomenon — more about it in our Nature feature here — are up to about 170.)

According to the update posted in July, an investigation into the paper by the Jiading Central Hospital in Shanghai, where the authors work, found that they “did not participate in influencing the peer review process.”

Here’s more from the update to the notice:

Continue reading BMC editors update retraction after investigation clears authors of faking peer reviews